---
figid: PMC9424309__41398_2022_2122_Fig1_HTML
figtitle: Direct and indirect targets of lithium which play a role in the PI3K/Akt
  insulin signaling pathway
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC9424309
filename: 41398_2022_2122_Fig1_HTML.jpg
figlink: /pmc/articles/PMC9424309/figure/Fig1/
number: F1
caption: 'a IMPase and IPP in the PI-Cycle. Lithium inhibits the activity of the PI-cycle
  in 2 areas: inositol monophosphatase (IMPase) and inositol polyphosphate-1-phosphatase
  (IIPase), thereby limiting the turnover rate of PIP2 available for PI3K signaling.
  b GSK3. Lithium inhibits GSK3 directly through uncompetitive inhibition of binding
  of the GSK3 cofactor magnesium and indirectly through activation of Akt. c PKC.
  Lithium acts to inhibit PKC translocation from the cytosol to the cell membrane.
  d SMIT. Lithium indirectly inhibits the activity and expression of SMIT, possibly
  through primary effects on the PI-Cycle. Li with an asterisk (*) indicates an indirect
  target of lithium. Li Lithium, IRS insulin receptor substrate, RTK tyrosine kinase
  adapter molecules, DAG diacylglycerol, PKC protein kinase C, SMIT sodium myo-inositol
  transporter, IMPase inositol monophosphatase, IPPase inositol polyphosphatase, IP1
  inositol (1) phosphate, IP2 inositol bisphosphate, IP3 inositol (1,4,5) triphosphate,
  PI phophotidylinositol, PIP phosphatidylinositide phosphate, PI3K phosphatidylinositol
  3-kinase, PIP2 phosphatidylinositol 4,5 bisphosphonate; PIP3 phosphatidylinositol
  3,4,5 triphosphate, Akt protein Kinase B, GSK3 glycogen synthase kinase-3.'
papertitle: Insulin signaling as a therapeutic mechanism of lithium in bipolar disorder.
reftext: Iain H. Campbell, et al. Transl Psychiatry. 2022;12:350.
year: '2022'
doi: 10.1038/s41398-022-02122-6
journal_title: Translational Psychiatry
journal_nlm_ta: Transl Psychiatry
publisher_name: Nature Publishing Group UK
keywords: Bipolar disorder | Molecular neuroscience
automl_pathway: 0.9487886
figid_alias: PMC9424309__F1
figtype: Figure
redirect_from: /figures/PMC9424309__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9424309__41398_2022_2122_Fig1_HTML.html
  '@type': Dataset
  description: 'a IMPase and IPP in the PI-Cycle. Lithium inhibits the activity of
    the PI-cycle in 2 areas: inositol monophosphatase (IMPase) and inositol polyphosphate-1-phosphatase
    (IIPase), thereby limiting the turnover rate of PIP2 available for PI3K signaling.
    b GSK3. Lithium inhibits GSK3 directly through uncompetitive inhibition of binding
    of the GSK3 cofactor magnesium and indirectly through activation of Akt. c PKC.
    Lithium acts to inhibit PKC translocation from the cytosol to the cell membrane.
    d SMIT. Lithium indirectly inhibits the activity and expression of SMIT, possibly
    through primary effects on the PI-Cycle. Li with an asterisk (*) indicates an
    indirect target of lithium. Li Lithium, IRS insulin receptor substrate, RTK tyrosine
    kinase adapter molecules, DAG diacylglycerol, PKC protein kinase C, SMIT sodium
    myo-inositol transporter, IMPase inositol monophosphatase, IPPase inositol polyphosphatase,
    IP1 inositol (1) phosphate, IP2 inositol bisphosphate, IP3 inositol (1,4,5) triphosphate,
    PI phophotidylinositol, PIP phosphatidylinositide phosphate, PI3K phosphatidylinositol
    3-kinase, PIP2 phosphatidylinositol 4,5 bisphosphonate; PIP3 phosphatidylinositol
    3,4,5 triphosphate, Akt protein Kinase B, GSK3 glycogen synthase kinase-3.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - pi
  - Ipp
  - CycE
  - cyc
  - IRSp53
  - IleRS
  - chico
  - Tie
  - Ras85D
  - InR
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
  - sgg
  - inaC
  - Pkc98E
  - aPKC
  - Pkc53E
  - ATPsynbeta
  - Atpalpha
  - SLC5A3
  - IKBKG
  - IARS1
  - IRS1
  - IRS2
  - IRS4
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - GSK3A
  - GSK3B
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - ATP8A2
---
